112 results
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
3:28pm
and described in the prospectus supplement relating to the applicable series.
Voting Rights. The holders of shares of a series of preferred stock will have … the voting rights provided by the applicable certificate of designation and as required by applicable law. These voting rights will be described
8-K
EX-4.2
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof
8-K
EX-4.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting … rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
9:17am
of our common stock, including any voting rights, until they exercise their Common Warrants, as applicable.
There is no established public trading … without limitation authority to fix by resolution or resolutions the dividend rights, dividend rate, conversion rights, voting rights, rights
424B5
bkms4vtw vol
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
dxa8t5q14t6mpax
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-4.1
h4h055g7
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
EX-4.2
yivevv2ttcfy
26 Mar 24
Entry into a Material Definitive Agreement
8:03am